全文获取类型
收费全文 | 29616篇 |
免费 | 2465篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 302篇 |
儿科学 | 880篇 |
妇产科学 | 463篇 |
基础医学 | 3939篇 |
口腔科学 | 555篇 |
临床医学 | 3146篇 |
内科学 | 6102篇 |
皮肤病学 | 348篇 |
神经病学 | 2724篇 |
特种医学 | 989篇 |
外国民族医学 | 3篇 |
外科学 | 3990篇 |
综合类 | 560篇 |
现状与发展 | 1篇 |
一般理论 | 19篇 |
预防医学 | 2913篇 |
眼科学 | 921篇 |
药学 | 2128篇 |
中国医学 | 32篇 |
肿瘤学 | 2137篇 |
出版年
2021年 | 457篇 |
2020年 | 318篇 |
2019年 | 511篇 |
2018年 | 538篇 |
2017年 | 380篇 |
2016年 | 438篇 |
2015年 | 533篇 |
2014年 | 765篇 |
2013年 | 1200篇 |
2012年 | 1757篇 |
2011年 | 1854篇 |
2010年 | 942篇 |
2009年 | 985篇 |
2008年 | 1657篇 |
2007年 | 1826篇 |
2006年 | 1738篇 |
2005年 | 1761篇 |
2004年 | 1690篇 |
2003年 | 1524篇 |
2002年 | 1490篇 |
2001年 | 532篇 |
2000年 | 542篇 |
1999年 | 572篇 |
1998年 | 406篇 |
1997年 | 311篇 |
1996年 | 321篇 |
1995年 | 278篇 |
1994年 | 242篇 |
1993年 | 217篇 |
1992年 | 364篇 |
1991年 | 350篇 |
1990年 | 361篇 |
1989年 | 349篇 |
1988年 | 309篇 |
1987年 | 299篇 |
1986年 | 329篇 |
1985年 | 275篇 |
1984年 | 266篇 |
1983年 | 212篇 |
1982年 | 229篇 |
1981年 | 211篇 |
1980年 | 193篇 |
1979年 | 245篇 |
1978年 | 184篇 |
1977年 | 165篇 |
1976年 | 151篇 |
1975年 | 133篇 |
1974年 | 138篇 |
1973年 | 153篇 |
1972年 | 111篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
4.
5.
6.
7.
A. Cattapan K. Browne D.M. Halperin A. Di Castri P. Fullsack J. Graham J.M. Langley B.A. Taylor S.A. McNeil S.A. Halperin 《Vaccine》2019,37(2):289-295
Introduction/Hypothesis
Recruitment of participants into phase 1 vaccine clinical trials can be challenging since these vaccines have not been used in humans and there is no perceived benefit to the participant. Occasionally, as was the case with a phase 1 clinical trial of an Ebola vaccine in Halifax, Canada, during the 2014–2016 West African Ebola virus outbreak, recruitment is less difficult. In this study, we explored the motivations of participants in two phase 1 vaccine trials that were concurrently enrolling at the same centre and compared the motivations of participants in a high-profile phase 1 Ebola vaccine trial to those in a less high-profile phase 1 adjuvanted seasonal influenza vaccine study.Methods
An online survey which included participants’ prior experience with clinical trials, motivations to participate (including financial incentives), and demographic information was developed to examine the motivations of healthy participants in two phase 1 clinical vaccine trials conducted at the Canadian Center for Vaccinology in Halifax, Nova Scotia. Participants were invited via email to complete the online survey. Readability and clarity were assessed through pilot testing.Results
A total of 49 (55.7%) of 88 participants of the two studies completed the survey (22 [55%] of 40 participants from the Ebola vaccine study and 27 [56.3%] of 48 from the adjuvanted influenza vaccine study). Motivations that were most frequently ranked among participants' top three in both trials were (1) wanting to contribute to the health of others, (2) wanting to participate in something important, (3) wanting to contribute to the advancement of science, and (4) wanting to receive an incentive such as money or a tablet.Conclusions/Recommendations
Although media attention and financial compensation were more often cited by Ebola vaccine trial participants as a reason to participate, both altruistic and self-interested factors were important motivations for participants in their decision to participate in a phase 1 vaccine clinical trial. 相似文献8.
9.
Theodore M. Brasky Roberta M. Ray Sandi L. Navarro Jeannette M. Schenk Alison M. Newton Marian L. Neuhouser 《International journal of cancer. Journal international du cancer》2020,147(5):1374-1384
We and others have reported associations between B vitamins principally involved in one-carbon metabolism and increased lung cancer risk; however, results for women have been inconsistent. Here we report on the association of supplemental vitamins B6, folic acid and B12 intake and lung cancer risk using data from the Women's Health Initiative (WHI) study of postmenopausal women. Between 1993 and 1998, 161,808 women were recruited to participate in the WHI at 40 clinical centers in the US. After exclusions, 159,232 women were available for analysis and followed prospectively for an average of 18.3 years. Among them, 3,836 incident lung cancer cases were diagnosed. At baseline, supplemental B vitamins from multivitamins, vitamin mixtures and individual supplements were assessed. Adjusted Cox regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for associations between supplemental B vitamin intake and lung cancer risk. Relative to no intake, women who took ≥50 mg/day of vitamin B6 had 16% (HR 0.84, 95% CI: 0.71–0.99) reduced lung cancer risk. Associations did not differ significantly by smoking status or lung cancer histology. Intakes of folic acid and vitamin B12 were not associated with risk. There is a need for replication of our findings from other large, prospective studies with similar high-quality measurement of supplement intakes before any recommendations can be made at present on B6 supplementation for lung cancer prevention in women. 相似文献
10.